Paul Mavor, an Australian and UK licensed pharmacist and the CEO and Founder of Health House International, recently spoke to us about Australia’s medical cannabis program, the testing and regulations in place, and the future outlook for cannabis in his country.
The New Zealand government passed a law on December 11, 2018, that will establish a regulated medical cannabis scheme within one year.
George Anastassov, the CEO of AXIM Biotech, recently spoke to us about the current good manufacturing methods (cGMPs) his company has developed, their significance to the market, and plans for the future.
An interview with Sue Sisley
An interview with Montel Williams
An interview with Uma Dhanabalan
An interview with Susan Audino
An interview with Jeffrey C. Raber
Giuseppe Cannazza and Cinzia Citti from the University of Modena and Reggio Emilia discuss the growing interest in the use of medicinal cannabis in Europe and the analytical challenges involved.
